233 related articles for article (PubMed ID: 15522308)
1. The effects of pretreatment with donor antigen and immunosuppressive agents on fully allogenic tracheal graft.
Suemitsu R; Yoshino I; Shoji F; Yamaguchi M; Tomita Y; Maehara Y
J Surg Res; 2004 Nov; 122(1):8-13. PubMed ID: 15522308
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
4. Donor antigen-presenting cells are important in the development of obliterative airway disease.
Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
[TBL] [Abstract][Full Text] [Related]
5. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model.
Nusair S; Or R; Junadi S; Amir G; Breuer R
Chest; 2005 Dec; 128(6):4024-9. PubMed ID: 16354876
[TBL] [Abstract][Full Text] [Related]
7. Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning.
Nusair S; Gincberg G; Almogi-Hazan O; Breuer R; Or R; Wallach-Dayan SB
Transpl Immunol; 2012 Dec; 27(4):184-8. PubMed ID: 22801052
[TBL] [Abstract][Full Text] [Related]
8. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
10. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
11. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
12. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
[TBL] [Abstract][Full Text] [Related]
13. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.
Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL
Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416
[TBL] [Abstract][Full Text] [Related]
14. Mixed allogeneic chimerism prevents obstructive airway disease in a rat heterotopic tracheal transplant model.
Gammie JS; Li S; Kawaharada N; Colson YL; Yousem S; Ildstad ST; Pham SM
J Heart Lung Transplant; 1998 Aug; 17(8):801-8. PubMed ID: 9730430
[TBL] [Abstract][Full Text] [Related]
15. Local IL-17 production and a decrease in peripheral blood regulatory T cells in an animal model of bronchiolitis obliterans.
Nakagiri T; Inoue M; Morii E; Minami M; Sawabata N; Utsumi T; Kadota Y; Ideguchi K; Tokunaga T; Okumura M
Transplantation; 2010 Jun; 89(11):1312-9. PubMed ID: 20393404
[TBL] [Abstract][Full Text] [Related]
16. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation.
Kuo E; Bharat A; Goers T; Chapman W; Yan L; Street T; Lu W; Walter M; Patterson A; Mohanakumar T
Ann Thorac Surg; 2006 Sep; 82(3):1043-50. PubMed ID: 16928532
[TBL] [Abstract][Full Text] [Related]
17. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the obliteration process by ventilation in a mouse orthotopic tracheal transplantation model.
Chen C; Zhang YZ; Zheng H; Xu BB; Gao W
Transplantation; 2009 Jun; 87(12):1762-8. PubMed ID: 19543051
[TBL] [Abstract][Full Text] [Related]
19. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation.
Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T
Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
